Brief: OncoArendi Therapeutics FY Net Result Turns To Profit Of 64.3 Mln Zlotys
March 31 (Reuters) - OncoArendi Therapeutics SA OAT.WA :
* REPORTS FY 2020 NET PROFIT 64.3 MILLION ZLOTYS VERSUS LOSS
OF
4.2 MILLION ZLOTYS YEAR AGO
* FY 2020 REVENUE 124.9 MILLION ZLOTYS VERSUS 2.0 MILLION
ZLOTYS
YEAR AGO
* FY 2020 OPERATING PROFIT 73.7 MILLION ZLOTYS VERSUS LOSS
OF 4.8
MILLION ZLOTYS YEAR AGO
Source text for Eikon: urn:newsml:reuters.com:*:nEM7SMTkTa
Further company coverage: OAT.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))
Recent news on Molecure SA
See all newsBrief: Molecure Q1 Net Loss 4.1 Mln Zlotys
Brief: Molecure Says Its In-Consortium Project Selected For Funding By Medical Research Agency
Brief: Molecure To Sell 4.12 Mln Series K Shares and 2.0 Mln Existing Shares At 5 Zlotys/Shr
Brief: Molecure Starts ABB For Up to 4.12 Mln New Series K Shares And Up To 2.0 Mln Existing Shares
Brief: Molecure Signs Conditional Investment Agreement With MS Galleon And Szumowski Investments